References
- Huang X Dixit VM . Drugging the undruggable: exploring the ubiquitin system for drug development. Cell Res.26 (4), 484 – 498 (2016).
- de Poot SAH Tian G Finley D . Meddling with Fate: the proteasomal deubiquitinating enzymes. J. Mol. Biol.429 (22), 3525 – 3545 (2017).
- Borodovsky A Kessler BM Casagrande R Overkleeft HS Wilkinson KD Ploegh HL . A novel active site-directed probe specific for deubiquitylating enzymes reveals proteasome association of USP14. EMBO J.20 (18), 5187 – 5196 (2001).
- Jung H Kim BG Han WH et al. Deubiquitination of Dishevelled by Usp14 is required for Wnt signaling. Oncogenesis2, e64 (2013).
- Xu D Shan B Sun H et al. USP14 regulates autophagy by suppressing K63 ubiquitination of Beclin 1. Genes Dev.30 (15), 1718 – 1730 (2016).
- Lee BH Lee MJ Park S et al. Enhancement of proteasome activity by a small-molecule inhibitor of USP14. Nature467 (7312), 179 – 184 (2010).
- Shinji S Naito Z Ishiwata S et al. Ubiquitin-specific protease 14 expression in colorectal cancer is associated with liver and lymph node metastases. Oncol. Rep.15 (3), 539 – 543 (2006).
- Wu N Liu C Bai C Han Y-P Cho WC Li Q . Overexpression of deubiquitinating enzyme USP14 in lung adenocarcinoma promotes proliferation through the accumulation of β-catenin. Int. J. Mol. Sci.14 (6), 10749 – 10760 (2013).
- Kemp M . Recent advances in the discovery of deubiquitinating enzyme inhibitors. Prog. Med. Chem.55, 149 – 192 (2016).
- D'Arcy P Brnjic S Olofsson MH et al. Inhibition of proteasome ubiquitinating activity as a new cancer therapy. Nat. Med.17 (12), 1636 – 1640 (2011).
- Tian Z D'Arcy P Wang X et al. A novel small molecule inhibitor of deubiquitylating enzyme USP14 and UCHL5 induces apoptosis in multiple myeloma and overcomes bortezomib resistance. Blood123 (5), 706 – 716 (2014).
- Dimmock RJ Padmanilayam MP Puthucode RN et al. A conformational and structure−activity relationship study of cytotoxic 3,5-bis(arylidene)-4-piperidones and related N-acryloyl analogues. J. Med. Chem.44 (4), 586 – 593 (2001).
- Wang X D'Arcy P Caulfield TR et al. Synthesis and evaluation of derivatives of the proteasome deubiquitinase inhibitor b-AP15. Chem. Biol. Drug Des.86 (5), 1036 – 1048 (2015).
- US National Library of Medicine . https://clinicaltrials.gov/ct2/show/NCT02372240 .
- Chen X Yang Q Xiao L Tang D Dou QP Liu J . Metal-based proteasomal deubiquitinase inhibitors as potential anticancer agents. Cancer Metastasis Rev.36 (4), 655 – 668 (2017).
- Liao Y Liu N Hua X et al. Proteasome-associated deubiquitinase ubiquitin-specific protease 14 regulates prostate cancer proliferation by deubiquitinating and stabilizing androgen receptor. Cell Death Dis.8 (2), e2585 (2017).
- Zhu Y Zhang Y Sui Z Zhang Y Liu M Tang H . USP14 de-ubiquitinates vimentin and miR-320a modulates USP14 and vimentin to contribute to malignancy in gastric cancer cells. Oncotarget8 (30), 48725 – 48736 (2017).
- President and Fellows of Harvard College: WO2012012712 (2012).
- Proteostasis Therapeutics, Inc.: WO2013112651 (2013).
- Hu M Li P Song L et al. Structure and mechanisms of the proteasome-associated deubiquitinating enzyme USP14. EMBO J.24 (21), 3747 – 3756 (2005).